Eichhorst, Barbara F <br/><br/>
Due to low infection rates no routine anti-infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine-based first line therapy.  [electronic resource] 

 -  British journal of haematology  Jan 2007 
 - 63-72 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-1048 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2141.2006.06382.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Infective Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Chi-Square Distribution<br/>Female<br/>Humans<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Leukopenia<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Remission Induction<br/>Respiratory Tract Infections--drug therapy<br/>Risk Factors<br/>Survival Rate<br/>Vidarabine--administration & dosage